Fierce Pharma

NOVEMBER 18, 2024

With several high-profile manufacturing outlays already in the books in Europe this year, Sanofi is returning to the bloc in a bid to boost production for a long-approved transplant treatment and a | Sanofi has unveiled a 40 million euro investment at its Lyon Gerland biomanufacturing site in France. The cash infusion will help bolster local production of the company’s polyclonal antibody Thymoglubulin for kidney transplant rejection, as well as expected future capacity needs for the type 1 diab

Manufacturing 289

Manufacturing 289

MedCity News

NOVEMBER 18, 2024

The future looks bright for the integrated specialty pharmacy model – for health systems, providers, and most importantly, for patients. The post Market Trends to Watch for Health Systems and Their Specialty Pharmacies appeared first on MedCity News.

Marketing 126

Marketing Patients Pharma 126

Fierce Pharma

NOVEMBER 18, 2024

Robert F. | In a contrarian take offered by BMO Capital Markets' Evan Seigerman, the analyst said Robert F. Kennedy Jr. may not rock the boat as much as feared for the biopharma industry.

Biopharma 299

Biopharma FDA Marketing 299

MedCity News

NOVEMBER 18, 2024

Evvy has launched a new line of prescription products to relieve vaginal discomfort. The products are available on the company’s website, with prices ranging from $35 to $59. The post Evvy Introduces Treatments for Common Vaginal Symptoms appeared first on MedCity News.

Prescription 115

Prescription 115

Advertisement

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

Sales Management

Fierce Pharma

NOVEMBER 18, 2024

The scope of Gilead Sciences' recent round of layoffs is coming into clearer view with the revelation that the company is planning more than 100 cuts at its corporate headquarters. | The scope of Gilead Sciences' recent round of layoffs is coming into clearer view with the revelation that the company is planning more than 100 cuts at its corporate headquarters.

288

288

pharmaphorum

NOVEMBER 18, 2024

Eli Lilly's tirzepatide has been shown to significantly cut cardiovascular risks in patients with obesity and a form of heart failure with few treatment options, in another big win for the GLP-1 receptor agonist class.The results from the SUMMIT trial of tirzepatide in obese patients with heart failure with preserved ejection fraction (HFpEF) showed that Lilly's drug cut the risk of cardiovascular mortality and worsening heart failure events by 38% over a median follow-up of roughly two years.

Patients 97

Patients 97

pharmaphorum

NOVEMBER 18, 2024

Using AI-powered PanEcho software for screening ECGs could deliver results more quickly and allow treatment to be started earlier.

105

105

Fierce Pharma

NOVEMBER 18, 2024

Months after filing for bankruptcy, VBI Vaccines is taking the next step in shuttering operations with the voluntarily withdrawal of its hepatitis B vaccine, PreHevbrio. | The company initiated a voluntary recall of its sole commercial product, 2021-approved PreHevbrio, after filing for Chapter 15 bankruptcy earlier this year.

147

147

pharmaphorum

NOVEMBER 18, 2024

Private equity company Brookfield has reportedly moved closer to taking control of Grifols, after months of disruption at the Spanish pharma company.A report in Spanish newspaper El Confidencial suggests that Brookfield is preparing to make a bid to take a 65% controlling stake in the drugmaker for €10.50 per share, worth around €7 billion ($7.4 billion).

Pharma 105

Pharma 105

Pharmaceutical Technology

NOVEMBER 18, 2024

The decision in Europe follows an approval granted by the US Food and Drug Administration (FDA) in March this year.

Food and Drug Administration 105

Food and Drug Administration Food FDA 105

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patients

pharmaphorum

NOVEMBER 18, 2024

Neurogene has halted patient enrolment in the high-dose arm of its trial of Rett syndrome gene therapy, sparking another run on its shares

Side effects 104

Side effects Patients 104

Copyright Clearance Center

NOVEMBER 18, 2024

In a rapidly evolving publishing landscape, the executive director of the CCC is taking the lead on addressing one of the industry’s most pressing concerns: the use of copyrighted material in artificial intelligence systems.

Leads 98

Leads 98

pharmaphorum

NOVEMBER 18, 2024

Shortly after a disappointing trial readout for Syndax's menin inhibitor Revuforj in one form of leukaemia, the company has claimed FDA approval in another

FDA 104

FDA 104

Pharmaceutical Technology

NOVEMBER 18, 2024

During AHA 2024, data were presented from the Phase III trial of plozasiran targeting adults with genetically or clinically diagnosed FCS,

98

98

Advertisement

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

Sales

pharmaphorum

NOVEMBER 18, 2024

AbbVie's Elahere is approved in EU, ending a 10-year wait for a new therapy for platinum-resistant ovarian cancer.

98

98

Pharmaceutical Technology

NOVEMBER 18, 2024

The EC has granted marketing authorisation for Sandoz's Afqlir for the treatment of various retinal diseases.

Marketing 98

Marketing 98

MedCity News

NOVEMBER 18, 2024

Approval of Syndax’s Revuforj for acute leukemia makes the twice-daily pill the first in a new class of drugs that block a cancer-driving protein called menin. Other companies developing menin inhibitors include Kura Oncology, Biomea Fusion, and Johnson & Johnson subsidiary Janssen. The post Syndax Pharmaceuticals Leukemia Drug Wins a First-in-Class FDA Approval appeared first on MedCity News.

Pharmaceutical 78

Pharmaceutical FDA Biopharma Pharma 78

Pharmaceutical Technology

NOVEMBER 18, 2024

The US FDA has approved Syndax Pharmaceuticals' Revuforj (revumenib) for treating acute leukaemia with KMT2A translocation.

FDA 97

FDA Pharmaceutical 97

Advertisement

Eversana Intouch

NOVEMBER 18, 2024

Download the Report This year’s EVERSANA INTOUCH annual trends forecast – our ninth! – is both smaller and bigger than those that have come before it. It’s smaller because while in previous years we looked at five to seven trends affecting marketers, this year we’re spotlighting only three. It’s bigger because the impact of these issues is almost impossible to overstate.

Marketing 59

Marketing Pharma Competition Patients 59

PharmaTimes

NOVEMBER 18, 2024

The companies will focus on mechanisms of action, dose selection and biomarker analyses

Pharmaceutical 72

Pharmaceutical 72

PharmaVoice

NOVEMBER 18, 2024

With only one approved drug on the market, companies like Inventiva Pharma are advancing MASH drugs and seeking a competitive edge.

Competition 64

Competition Pharma Marketing 64

Contrarian Sales Techniques

NOVEMBER 18, 2024

Have you ever gone to a pharmacy with a prescription, only to find out the medicine isn’t in stock? It’s a bit of a letdown, right? But here’s the good news: Pharmacists in Malaysia are allowed to suggest alternatives that are just as effective, and sometimes even more affordable. Let’s talk about how they do it and why it matters. What Does It Mean to Recommend an Alternative?

Medicine 52

Medicine Prescription Training Sales 52

Advertisement

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

Sales

Pharmacy Times

NOVEMBER 18, 2024

The disorder presents as severe lung disease, with lung transplantation as the only current therapeutic option for long-term survival.

FDA 61

FDA 61

European Pharmaceutical Review

NOVEMBER 18, 2024

Sanofi is investing over €40 million in its Lyon Gerland site, supporting antibody bioproduction in France. A portion of this, €25 million, will be directed toward production and development of Sanofi’s second generation of its polyclonal antibody Thymoglubulin. It is used for transplantation and is manufactured exclusively at the Lyon Gerland site, Sanofi stated.

Manufacturing 64

Manufacturing Medicine Patients Management 64

PharmaVoice

NOVEMBER 18, 2024

Merck’s acquisition of Modifi Biosciences bucks common M&A trends in pharma.

Pharma 59

Pharma 59

Pharmacy Times

NOVEMBER 18, 2024

Lazertinib in combination with amivantamab displays positive outcomes for non–small cell lung cancer compared with standard first line treatment.

58

58

Advertisement

Distribution

Contrarian Sales Techniques

NOVEMBER 18, 2024

Have you noticed how government clinics can charge so little for medicines, or even give them away for free at times? If you’ve been to one, you’ve probably seen how affordable it is. But what’s the secret behind this? Let’s unpack the system that makes healthcare so accessible for Malaysians. How Does It Work? Government clinics get their medicines directly from suppliers, often in bulk, at negotiated prices.

Government 52

Government Medicine Insurance Healthcare 52

Pharmacy Times

NOVEMBER 18, 2024

Rachel Chandra, PharmD, MPH, FASHP, shares insight into the VALOR-QI program.

55

55

Pharmaceutical Commerce

NOVEMBER 18, 2024

The latest news for pharma industry insiders.

Pharma 52

Pharma FDA 52

Pharmacy Times

NOVEMBER 18, 2024

Factors such as age, race, marital status, years since diagnosis, and out-of-pocket costs show significance as predictors of quality of life.

52

52

Advertisement

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A

Sales